StocksRunner logo
mail
search
 
menu
 
Regeneron Pharma
$577.95
+0.39%
 
  Create Alerts  
  
  Overview  
  
  Comments  
  
  Insights  
  
     Risks     
  
  Rating  
  
     Chart     
  
  Analysts  
  
  Street  
  
  Sentiment  
  
  Earnings  
  
  Headlines  
 

REGN Stock Analysis & IQ Rating | Regeneron Pharmaceuticals

 
 
 

REGN

 

Regeneron Pharma

$577.95

 
+$2.26 | +0.39%
 
  Create Alerts  
  
  Overview  
  
  Comments  
  
  Insights  
  
     Risks     
  
  Rating  
  
     Chart     
  
  Analysts  
  
  Street  
  
  Sentiment  
  
  Earnings  
  
  Headlines  
 
 
52W High
$ 943.77
 
 
MKT CAP
$ 61.26B
 
52W Low
$ 476.49
 
 
VOL
$ 641.03K
 
P/E Ratio
14.56
 
 
AVG VOL
$ 1.07M
 
RSI
51.60
 
 
TREND
Uptrend
 
 
 

REGN Stock IQ

 
lock  Login to see Regeneron Pharma (REGN) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid
 
 

REGN Target Price

 
 
 

Strengths

 

REGN Rewards

 Earnings are forecast to grow

REGN Rewards

 Upgraded on attractively valued

REGN Rewards

 Trading below its fair value

 
 

Chart

 
 

$560.75   (+3.07%)

$558.87   (+3.41%)

$484.93   (+19.18%)

$824.48   (-29.90%)

 
 
1year
6month
3month
1month
 

REGN Risk Level

 

REGN has Low Risk Level based on volatility, sector strength, volume, investor confidence, and outlook. Click here to check what is your level of risk

 
 
 
REGN Risk Level
LOW
HIGH
 

REGN Analysts Opinion

 

REGN overall standing based on key factors, offering insights into analysts perspectives and market expectations.
menu Hover over the category for more information

 
 

Earnings

×
 

Earnings

 

REGN Earnings Sentiment

 Above analyst estimates

 
 

Rating

×
 

Rating

 

REGN Rating Sentiment

 Upgraded on attractively valued

 

Momentum

×
 

Momentum

 

REGN Momentum Analysis

 Has been gaining momentum

 

Activity

×
 

Activity

 
 

Future

×
 

Future

 

REGN Future Sentiment

 Earnings are forecast to grow

REGN Future Sentiment

 Trading below its fair value

 
 

REGN Analysts Opinion

REGN Analysts opinion is positive and also has improved from the past 3 months

 

REGN Street Consensus

 

Analysts perspectives on the stock desirability, trend direction, and growth potential.

 
75%
Buy
Opinion
Trend
Score
Potential
Score
 
Consensus Rating
 
100%
25%
55%
 

REGN Street Opinion 

REGN Street view is bullish but have mixed views on the near-term outlook

 

REGN Performance Sentiment

 
Sentiments overview associated with REGN events and the stock performance.
 
75%
25%
Positive
Negative
27 out of 36
events present
9 out of 36
events present
 
Very Bullish
Bullish
Neutral
Bearish
Very Bearish
 
 

Technical Price Levels

 

Average key support and resistance price levels.

 
lock  Login to display
 
Support
Price
 
$574.23
 
Resistance
Price
 
$555.51
 
 
Current Price Range
 
$604.91
 
 
Show methods +
 
 
 
REGN Latest Analysis +
 
 
FAQ About REGN Stock Insights
 

What is REGN current stock price?

What are REGN stock strengths?

What risks are associated with REGN stock?

When is REGN next earnings report?

What is REGN market cap and volume?

What is REGN's current Stock IQ?

Should I buy REGN stock right now?

Is REGN a Strong Buy right now?

What does a 'Strong Buy' rating mean for REGN?

What does a 'Strong Sell' rating mean for REGN?

What factors influence REGN's Stock IQ?

 
 
StocksRunner

Explore our REGN Stock insights

  • In-Depth Market Analysis and Trends
  • Expert Insights on Market Dynamics
  • Tailored REGN Stock Strategies
  • Effective Risk Management
 

FIND US ON

StocksRunner on Facebook StocksRunner on Twitter StocksRunner on YouTube StocksRunner on stocktwits StocksRunner Rss
 

Receive our REGN Daily Alerts

Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts

 
Market Trends

Stay ahead of the market

Market trends

Investment tips

Market analysis service

 
Investment Insights

Future potential

Informed investment decisions

Investment analysis

IInvestment strategies

 
Stock Analysis

In-depth stock analysis

Performance analysis

Stock market insights

Financial trends analysis

 
About StocksRunner

Log In

Sign Up

Plans & Pricing

Contact Us

Terms of use

Privacy Policy

 
 
StocksRunner
 
 
StocksRunner Overview
 
StocksRunner Trending
 
StocksRunner Screener
 
StocksRunner Insights
 
StocksRunner Top Rated
 
StocksRunner Momentum
 
StocksRunner Earnings
 
StocksRunner Leaders
 
 

REGN

 

Regeneron Pharma

 
 

Current Price

 

$577.95

 
+$2.26 | +0.39%
 
 
52W High
$ 943.77
 
 
MKT CAP
$ 61.26B
 
52W Low
$ 476.49
 
 
VOL
$ 641.03K
 
P/E Ratio
14.56
 
 
AVG VOL
$ 1.07M
 
RSI
51.60
 
 
TREND
Uptrend
 
 
 
  Create Alerts  
  
  Overview  
  
  Comments  
  
  Insights  
  
   Risks   
  
  Rating  
  
  Chart  
  
  Analysts  
  
  Street  
  
  Sentiment  
  
  Earnings  
 
 
 
 

Target Price

 
 
 
 
Not Enough Information
 
 
 
 

Stock Insights

 
 
 
 

Strengths

 

REGN Rewards

 Earnings are forecast to grow

REGN Rewards

 Upgraded on attractively valued

REGN Rewards

 Trading below its fair value

 
 
 
 
 

REGN Stock IQ

 
lock  Login to unlock Regeneron Pharma (REGN) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid
 

Chart

 
 

$560.75   (+3.07%)

$558.87   (+3.41%)

$484.93   (+19.18%)

$824.48   (-29.90%)

 
 
1year
6month
3month
1month
 

REGN Analysts Opinion

 

REGN Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
menu Hover over the category for more information

 
 

Earnings

×
 

Earnings

 

REGN Earnings Sentiment

 Above analyst estimates

 
 

Rating

×
 

Rating

 

REGN Rating Sentiment

 Upgraded on attractively valued

 

Momentum

×
 

Momentum

 

REGN Momentum Sentiment

 Has been gaining momentum

 

Activity

×
 

Activity

 
 

Future

×
 

Future

 

REGN Future Sentiment

 Earnings are forecast to grow

REGN Future Sentiment

 Trading below its fair value

 
 

REGN Analysts Opinion

REGN Analysts opinion is positive and also has improved from the past 3 months

 

REGN Street Consensus

 

Analysts perspectives on the stock desirability, trend direction, and growth potential.

 
75%
Buy
Opinion
Trend
Score
Potential
Score
 
Consensus Rating
 
100%
25%
55%
 

REGN Street Opinion 

REGN Street view is bullish but have mixed views on the near-term outlook

 

REGN Risk Level

 

REGN has Low Risk Level based on volatility, sector strength, volume, investor confidence, and outlook. Click here to check what is your level of risk

 
 
 
REGN Risk Level
LOW
HIGH
 
REGN Performance Sentiment
 
Sentiments overview associated with REGN events and the stock performance.
 
75%
25%
Positive
Negative
27 out of 36
events present
9 out of 36
events present
 
Very Bullish
Bullish
Neutral
Bearish
Very Bearish
 

Technical Price Levels

 

Average key support and resistance price levels.

 
lock  Login to display
 
Support
Price
 
$574.23
 
Resistance
Price
 
$555.51
 
 
Current Price Range
 
$604.91
 
 
Show methods +
 
 
 
 
 
 
 

REGN Latest Analysis

 
 
 

REGN Q3 Earnings: Will Higher Dupixent Profits Offset Eylea Sales Decline?. Regenerons Q3 earnings on Oct. 28 will likely spotlight Dupixent profits and strong Eylea HD uptake amid lingering Eylea competition.

 

Fri Oct 24, 2025

$577.95 | +0.39%
 
Activity

Canaccord Genuity Maintains Regeneron Pharmaceuticals (REGN) Buy Recommendation. Fintel reports that on October 23 2025 Canaccord Genuity maintained coverage of Regeneron Pharmaceuticals (NasdaqGS:REGN) with a Buy recommendation. Analyst Price Forecast Suggests 29.33% Upside

 

Fri Oct 24, 2025

$577.95 | +0.39%
 
Rating

Exploring Analyst Estimates for Regeneron (REGN) Q3 Earnings Beyond Revenue and EPS. Evaluate the expected performance of Regeneron (REGN) for the quarter ended September 2025 looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.

 

Thu Oct 23, 2025

$575.69 | -1.55%
 
Earnings

Emphysema Market Analysis Reveals Promising Growth Opportunities and Trends During the Forecast Period (2025-2034) | DelveInsight. The emphysema market is anticipated to grow steadily fueled by a range of emerging therapies under development. Leading candidates like SAR447537 (Sanofi) Alvelestat (Mereo BioPharma) BEAM-302 (Beam Therapeutics) itepekimab (Regeneron Pharmaceuticals/Sanofi) depemokimab (GSK) and...

 

Tue Oct 21, 2025

$579.34 | +0.45%
 
Potential

Earnings Preview: Regeneron (REGN) Q3 Earnings Expected to Decline. Regeneron (REGN) doesnt possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

 

Tue Oct 21, 2025

$579.34 | +0.45%
 
Earnings

Heres How Much $1000 Invested In Regeneron Pharmaceuticals 20 Years Ago Would Be Worth Today. Regeneron Pharmaceuticals (NASDAQ:) has outperformed the market over the past 20 years by 12.6% on an annualized basis producing an average annual return of 21.67%. Currently Regeneron Pharmaceuticals has a market capitalization of $62.41 billion.

 

Mon Oct 20, 2025

$576.53 | -0.26%
 
Activity

Benjamin Graham Detailed Fundamental Analysis - REGN. Below is Valideas guru fundamental report for REGENERON PHARMACEUTICALS INC (REGN). Of the 22 guru strategies we follow REGN rates highest using our Value Investor model based on the published strategy of Benjamin Graham. This deep value methodology screens for stocks that hav

 

Mon Oct 20, 2025

$576.53 | -0.26%
 
Potential

Benjamin Graham Detailed Fundamental Analysis - REGN. Below is Valideas guru fundamental report for REGENERON PHARMACEUTICALS INC (REGN). Of the 22 guru strategies we follow REGN rates highest using our Value Investor model based on the published strategy of Benjamin Graham. This deep value methodology screens for stocks that hav

 

Fri Oct 17, 2025

$578.05 | +1.56%
 
Potential

REGN Reports Encouraging Data on Gene Therapy for Genetic Hearing Loss (Revised). Regenerons DB-OTO gene therapy shows hearing gains in nearly all CHORD study participants with durable and meaningful improvements.

 

Thu Oct 16, 2025

$569.17 | -1.26%
 
Activity

REGN Factor-Based Stock Analysis - Benjamin Graham. Below is Valideas guru fundamental report for REGENERON PHARMACEUTICALS INC (REGN). Of the 22 guru strategies we follow REGN rates highest using our Value Investor model based on the published strategy of Benjamin Graham. This deep value methodology screens for stocks that hav

 

Wed Oct 15, 2025

$576.42 | +0.67%
 
Potential

 
 
 
 
 
StocksRunner

Discover REGN Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends, and the future potential of REGN. We're here to help you make informed investment decisions today.

 

FIND US ON

StocksRunner on Facebook StocksRunner on Twitter StocksRunner on YouTube StocksRunner on stocktwits StocksRunner Rss

 

Receive our REGN Daily Alerts

Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts

 
Market trends

In-depth stock analysis

Informed investment decisions

Stock market insights

Stock trading tips

Stock analysis

REGN Stock trends

REGN Stock performance

REGN Stock analysis

REGN investment strategies

Stock strategies

Trading strategies

StocksRunner updates

StocksRunner Insights

Financial Reports

 
 

Disclaimer: Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor. The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses. Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

 
 
StocksRunner logo
 

REGN Runner Alarm

Real-time signals powered by data
×

Price-Based

Triggers when the stock breaks through a known resistance level
 
Triggers when the stock drops below a key support level
 
Notifies if the stock moves up/down by a set percentage (e.g. ±5%)
 
Alerts when the stock hits a new high or low
 
Signals proximity to long-term highs or lows (e.g. within 5%)
 

Technical Indicator (Pro Plan)

Volume spikes 2x–3x above average. Indicates strong buying/selling pressure
 
Tracks large intraday swings, signaling potential opportunities or risk
 
Signals potential trend reversals or continuations
 
Long-term bullish/bearish trend signals from MA crossovers
 
RSI above 70 or below 30 to identify possible reversals
 
Signals momentum shifts
 

Fundamental (Master Plan)

Upcoming or just-released earnings reports
 
Alerts after results compared to expectations
 
Changes in rating or target price
 
New or changed dividends
 
Large trades by company insiders
 
M&A, lawsuits, product launches, etc
 
High volume/open interest in call/put contracts
 
Surge in mentions or sentiment shifts
 

 
 
Post ×
 
0/666
joker
 
 
 
 
StocksRunner logo
 

Don't Be a Sheep, Be a StocksRunner

 

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

 
StocksRunner thumbnail
 
 

Sign up for free and

continue analysing REGN

 
Signup to Stocksrunner
 

Already a Member? Click here to Login

 

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence, and cutting-edge intelligence.

 
 
StocksRunner logo
 

Don't Be a Sheep, Be a StocksRunner

 

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

 
StocksRunner thumbnail
 
 

Sign up for free and

continue analysing REGN

 
Signup to Stocksrunner
 

Already a Member? Click here to Login

 

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence, and cutting-edge intelligence.